![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2007, Cold Spring Harbor Laboratory Press IRES-mediated functional coupling of transcription and translation amplifies insulin receptor feedback 1 Howard Hughes Medical Institute, Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California 94720, USA; 2 University of Helsinki, Institute of Biotechnology, Helsinki FI-00014, Finland 3Corresponding author. E-MAIL jmlim/at/uclink4.berkeley.edu; FAX (510) 643-9547. Received October 30, 2006; Accepted November 17, 2006. This article has been cited by other articles in PMC.Abstract It is generally accepted that the growth rate of an organism is modulated by the availability of nutrients. One common mechanism to control cellular growth is through the global down-regulation of cap-dependent translation by eIF4E-binding proteins (4E-BPs). Here, we report evidence for a novel mechanism that allows eukaryotes to coordinate and selectively couple transcription and translation of target genes in response to a nutrient and growth signaling cascade. The Drosophila insulin-like receptor (dINR) pathway incorporates 4E-BP resistant cellular internal ribosome entry site (IRES) containing mRNAs, to functionally couple transcriptional activation with differential translational control in a cell that is otherwise translationally repressed by 4E-BP. Although examples of cellular IRESs have been previously reported, their critical role mediating a key physiological response has not been well documented. Our studies reveal an integrated transcriptional and translational response mechanism specifically dependent on a cellular IRES that coordinates an essential physiological signal responsible for monitoring nutrient and cell growth conditions. Keywords: 4E-BP, Foxo, IRES, insulin receptor Coupled transcription and protein synthesis is a hallmark of prokaryotic gene expression. The advantages of such a linked system are well recognized as it provides smooth coordination to ensure that cells respond appropriately to signals such as nutrient availability. A rapid response to such environmental signals also allows for multiple points of regulation and a fine-tuning mechanism for controlling gene expression. In eukaryotic organisms, the compartmentalization of the cell nucleus makes the direct coupling of transcription and translation problematic. Nevertheless, like prokaryotes, the metazoan cell must respond to many external as well as internal signals, and a coupled response would be highly advantageous. However, there is currently little evidence for such a direct linkage, either physical or functional, in metazoans. In our attempts to dissect the transcriptional regulatory circuitry of the insulin-like signaling cascade in Drosophila, we have discovered a potentially new mechanism that functionally links transcription and translation. Metazoan organisms must strictly control both body and organ size during development (Conlon and Raff 1999). Thus, cell size and cell number are tightly controlled to determine the final size of an animal. One of the cues used in determining growth regulation is nutrient availability (Hafen 2004; Puig and Tjian 2006). The insulin receptor (INR) and insulin-like growth factor (IGF) receptor pathways have evolved as key sensors of nutrient availability and play an important role in both cell-autonomous and nonautonomous decisions controlling cellular proliferation, cell size determination, and the response to nutrient availability. In Drosophila, this pathway is critical for determining body and organ size as well as metabolic homeostasis and life span. Perhaps most notably, misregulation of this pathway in humans can lead to type 2 diabetes and all of its associated pathologies, which is becoming a rapidly escalating worldwide epidemic (Saltiel and Kahn 2001). The INR/IGF pathway is highly conserved, with homologs of the key molecular players present in metazoan organisms from flies to humans (Garofalo 2002). The downstream targets of this signaling cascade are thought to separately modulate both transcription and translation to potentiate signals for either growth or stasis. In the presence of insulin or insulin-like peptides, the signaling cascade activates the oncogenic protein kinase Akt. To control RNA synthesis, Akt phosphorylates the Forkhead-box-binding protein (dFOXO) family of transcription factors, sequestering them in the cytoplasm and thus effectively inactivating them. This in turn prevents activated transcription of the dFOXO target genes. In addition, Akt stimulates the modification of the target of rapamycin (TOR) protein, which in turn phosphorylates and inactivates the translation initiation inhibitor eIF4E-binding protein (d4E-BP). In its unphosphorylated and active state, d4E-BP binds to the 7-methyl-guanosine (m7G) cap-binding protein eIF4E. This prevents formation of the translation initiation complex eIF4F, thereby inhibiting cap-dependent translation (Ruggero and Sonenberg 2005). This combination of inactivated dFOXO and inactive d4E-BP efficiently drives the cell toward growth and proliferation (Fig. 1
Results Drosophila melanogaster has proven to be a valuable model organism for working out the molecular details of this conserved pathway (Brogiolo et al. 2001; Miron et al. 2001; Tatar et al. 2001; Junger et al. 2003; Puig et al. 2003; Puig and Tjian 2005). We have recently shown that in the absence of insulin or insulin-like peptides, dFOXO activates the transcription of both the insulin-like receptor (dINR) gene and the gene for Drosophila 4E-BP, establishing a transcriptional signaling loop that sensitizes the cell to receive further nutrient-dependent signals while preventing the cell from proliferating (Puig et al. 2003; Puig and Tjian 2005). In order to investigate this intriguing transcriptional feedback control, we first precisely mapped the start site of transcription for the dINR gene using a modification of the cap-trapping cDNA synthesis method (Carninci et al. 1997). This method, which depends on an intact m7G cap for capture of the mRNA, when combined with rapid amplification of five prime (5′) cDNA ends (5′ RACE) maximizes the yield of full-length 5′ untranslated regions (UTRs). The use of this methodology allowed us to detect critical UTRs associated with the mRNA that had previously gone undocumented. We find that the dINR gene is actually controlled by a complex set of three distinct promoters (P1, P2, and P3) spread over 38 kb of the Drosophila genome (Fig. 2A
Each of the dINR promoters produces a transcript with a unique and unusually long 5′UTR spliced to a short common exon that is in turn spliced to the first coding exon (Supplemental Material). The UTR originating from P1 is 1118 bases, the UTR originating from P2 is 419 bases, and the UTR originating from P3 is 485 bases. In contrast, the average 5′UTR in Drosophila is only 256 bases (Misra et al. 2002). All three UTRs contain multiple AUG initiator codons upstream of the legitimate INR initiator codon. In the case of the transcript that originates from P1, there are 12 AUGs before the legitimate translational start signal. The DNA sequences immediately upstream of the mapped transcript start sites contain easily recognizable sequences similar to the computationally and biochemically determined common core promoter elements (Sanders et al. 1986; Burke and Kadonaga 1997; Ohler et al. 2002). P1 contains a TATA box, an Initiator element, and a downstream promoter element (DPE). P2 contains a TATA-like box and a DPE but no recognizable Initiator. P3 contains a recognizable Initiator but no recognizable TATA box or DPE. Importantly, a constitutively active form of dFOXO (dFOXO-A3) (Puig et al. 2003) activates all three promoters in Drosophila Schneider line 2 (S2) cells, and this increased RNA synthesis can produce dINR protein even in the presence of insulin (Fig. 2B,C In the animal, all three transcripts are detectable in multiple developmental stages. They are present in whole animal extracts in the same relative order of abundance that is detected in S2 cells (P1 P2 > P3) (Fig. 2CStrikingly, we find that dINR is not only transcriptionally up-regulated (Puig et al. 2003; Puig and Tjian 2005) but also robustly translated. Growing S2 cells in the absence of serum and insulin causes a marked decrease in the rate of incorporation of radiolabeled cysteine and methionine consistent with a global decrease in the rate of translation (Fig. 3A
As a first test of whether the dINR 5′UTRs also contain an IRES activity, we generated a bicistronic construct commonly used to assess IRES activity. The various 5′UTRs of dINR were inserted in both the forward and reverse orientations between the Renilla and firefly luciferase genes (Fig. 4A
To circumvent some of the inherent idiosyncrasies of the bicistronic constructs, we next used monocistronic constructs that more closely mimic the situation of the endogenous dINR gene. We tested for potential IRES activity in two complementary ways. First, in a DNA-based transient transfection, we expressed either the constitutively active form of d4E-BP or a control protein, green fluorescent protein (GFP), and measured resistance to d4E-BP as the ratio of luciferase activity (provided by a second plasmid) in the presence of d4E-BP to the activity in the presence GFP (Fig. 4B However, given the well-recognized limitations inherent with using cell-based assays to establish IRES activity, we turned to a Drosophila embryo-derived capdependant in vitro translation system to test more directly the putative IRES activity and more specifically the potential d4E-BP resistance of the INR UTRs (Gebauer et al. 1999; Tuschl et al. 1999). We first treated the translation extracts with micrococcal nuclease to destroy the bulk of competing endogenous transcripts so that translation would be largely dependent on exogenously added RNA (Sanders et al. 1986). As expected, addition of normal capped transcripts results in robust translation from all of the UTR-containing RNAs as well as the common UTR and a short nonspecific UTR control RNA (Fig. 5A
What purpose might a cap-independent translation activity serve beyond simple resistance to the active d4E-BP in the absence of insulin? Perhaps by functionally coupling transcription and translation, such a mechanism could serve to amplify the signal received from the insulin receptor pathway. To test this idea, we again turned to the in vitro translation experiments. In the absence of miccrococal nuclease treatment, the endogenous transcripts present in the translation extract should effectively compete with the experimental dINR transcripts for limiting amounts of the translation machinery (Svitkin et al. 2005). We therefore took advantage of this inevitable competition for translation machinery to test the response of the various UTRs in a situation that may more closely reflect the cellular environment, where multiple variable abundant transcripts must compete for a limited supply of the translational apparatus. Under these competitive conditions, addition of either m7G or d4E-BP actually results in an even more robust increase in translation of the dINR UTR-containing RNAs relative to the unchallenged state (Fig. 6A,B
Discussion The data we report here, combined with our previous data and those from others, allow us to formulate a new model to explain the effects of nutrients and insulin levels on dINR feedback regulation. In times of high nutrients and therefore high insulin-like peptides, both dFOXO and d4E-BP are phosphorylated and inactive. Under these “rich” conditions, dFOXO is sequestered in the cytoplasm and phosphorylated d4E-BP is unable to interact with eIF4E. This situation allows efficient translation of most cellular transcripts regardless of the mechanism of initiation (cap-dependent vs. cap-independent) (Fig. 7A
Interestingly, the dFOXO-responsive dINR promoters produce three distinct transcripts. Why such a complex regulatory network? A hint may be that the P3 UTR does not seem to have detectable IRES activity in the S2 cells but shows substantial activity in vitro with extracts derived from whole Drosophila embryos. It is likely that the three transcripts are produced in a tissue- or temporal-specific manner during development, and we speculate that each may depend on cell-specific IRES trans-acting factors (ITAFs) that are required for activity. This would direct tissues to respond differentially to dINR signaling. In tissues lacking specific ITAFs, the IRES activity would be diminished and the tissue may produce only a moderate level of dINR protein. We also find an interesting parallel between mechanisms for reprogramming the gene expression machinery in a cell to respond to physiological cues and the more commonly observed viral takeover of the cellular macromolecular synthesis machinery (Svitkin et al. 2005). When some viruses, such as polio, infect a cell, they target the translation initiation machinery (either eIF4G or 4E-BP) so that there is a switch from cap-dependent synthesis to IRES-dependent synthesis (Jackson 2005). This leads to a robust and specific stimulation of viral protein synthesis at the expense of most cellular protein synthesis. By the evolution of cellular mechanisms that activate 4E-BP and simultaneously produce transcripts containing cellular IRESs, a critical physiological signaling cascade can evidently adopt a similar mechanism to effectively usurp the macromolecular synthesis machinery to drive cellular physiology in a very specific direction. Indeed, viruses may have merely co-opted the mechanism from cells in the eternal battle between host and virus. Although our initial characterization of the INR transcriptional feedback loop was carried out in Drosophila, we subsequently found a similar regulatory circuit in vertebrates (Puig et al. 2003; Puig and Tjian 2005). It is interesting to note that the transcripts for human insulin receptor and IGF-2 receptor remain associated with polysomes when cap-dependant translation is inhibited by poliovirus infection (Johannes et al. 1999). We have also observed that although the level of INR mRNA up-regulation by FOXO in mouse muscle cells is only twofold, the levels of INR protein increase much more dramatically (six- to eightfold), consistent with a coupled transcription/translation mechanism of the signal in vertebrates (Puig and Tjian 2005). It seems likely, given the findings we report here, that the same type of coupling between the transcriptional program of FOXO proteins and translational control by IRES activity is also occurring in vertebrate systems. Understanding this novel mechanism that couples transcription and translation may provide new insight into disease states such as insulin-resistant type 2 diabetes. Materials and methods Cell culture Drosophila S2 cells were maintained at 25°C in M3BPYE as described by the Drosophila Genomics Resource Center (http://dgrc.cgb.indiana.edu) supplemented with 10% fetal bovine serum (FBS) and 5 μg/mL bovine insulin pen per strep, and 2 mM glutamine (complete media). S2 cells expressing dFOXO or dFOXO-A3 have been described (Puig et al. 2003). For dFOXO induction in Figure 2D Transient transfection For expression in S2 cells, the dINR UTR-containing constructs and the d4E-BP constructs were driven by a version of the Actin 5C promoter truncated to remove negative elements (Chung and Keller 1990). The expression plasmid in Figure 3A For RNA transfections, RNA was transcribed in vitro in the presence of m7G(5′)ppp(5′) or G(5′)ppp(5′)A cap analog (New England Biolabs) using Megascript T7 kits (Ambion). RNA was purified on a G-50 spin column and by LiCl precipitation. S2 cells were transfected in 24-well plates with 100 ng of firefly reporter and 50 ng of capped Renilla RNA as a transfection control using Effectene Reagent (Qiagen). Luciferase activity was measured 24 h post-transfection. Cloning of the dINR 5′UTRs The dINR UTRs were mapped using the cap-trapper methodology as previously described with the following modifications (Carninci et al. 1997). A gene-specific primer that hybridized to the dINR ORF was used for first-strand synthesis using poly(A)-purified RNA. RNase protection was performed with RNase A and RNase T1. The RNA/DNA hybrid was purified by biotinylated cap as previously described. The single-stranded cDNA was purified by a combination of RNase H and NaOH treatment followed by spin column purification (Qiagen). The first strand was dC tailed using terminal deoxytransferase. The 5′UTRs were amplified by two rounds of nested PCR and cloned into pCR4 (Invitrogen) and sequenced. Detailed protocol is available upon request. Intron/exon boundaries were deduced by mapping the UTR sequences onto the Drosophila genomic sequence. In vitro translation Embryo translation extracts were prepared as described from 0- to 12-h embryos (Gebauer et al. 1999; Tuschl et al. 1999). In vitro transcription templates were linearized with XhoI and purified on Qiagen spin columns. Capped transcripts were generated with mMessage mMachine T7 Ultra kits (Ambion), desalted on a G-50 spin column, and precipitated with LiCl. Transcripts were resuspended in 10 mM Tris-HCl (pH 8.5). Transcription products were checked on denaturing agarose gels. In vitro translation reactions contained 6 μL of Drosophila embryo extract, 0.1 mM spermidine, 60 μm Amino Acids total (Roche), 16.8 mM creatine phosphate, 800 ng of creatine kinase, 24 mM HEPES (pH 7.4), 0.4 mM Mg acetate, 30 mM K acetate, 1 μg of calf liver tRNA, and 12 ng of template RNA in a 10-μL reaction. 3′-0-Me-7meG(ppp)G RNA Cap Structure Analog (New England Biolabs), GST-d4E-BP, or GST was added to a final concentration of 500 nm. Reactions were preincubated for 10 min at 27°C before the addition of RNA templates. Translation was conducted for 40 min at 27°C, and luciferase activity was measured using 8 μL of the reaction in 100 μL of luciferase substrate (Promega). Acknowledgments We thank Jennifer Doudna and Wendy Gilbert for critical reading of the manuscript and for sharing data prior to publication. We also thank Nahum Sonenberg for comments on the manuscript. We thank Yoh Isogai, Kevin Wright, Yick Fong, and Francisco Herrera for comments and suggestions on the manuscript; and Mallory Haggart for sequencing and oligonucleotide synthesis. We thank Fatima Gebauer for the Antennapedia construct and for advice on making the Drosophila translation extracts. M.T.M. was supported by a fellowship from the Damon Runyon Cancer Research Foundation (DRG #1684) for part of this work. R.T. is supported by grants from the NIH and Howard Hughes Medical Institute. Footnotes Supplemental material is available at http://www.genesdev.org. Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1506407 References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Cell. 1999 Jan 22; 96(2):235-44.
[Cell. 1999]Swiss Med Wkly. 2004 Dec 18; 134(49-50):711-9.
[Swiss Med Wkly. 2004]Cell Cycle. 2006 Mar; 5(5):503-5.
[Cell Cycle. 2006]Nature. 2001 Dec 13; 414(6865):799-806.
[Nature. 2001]Trends Endocrinol Metab. 2002 May-Jun; 13(4):156-62.
[Trends Endocrinol Metab. 2002]Oncogene. 2005 Nov 14; 24(50):7426-34.
[Oncogene. 2005]Curr Biol. 2001 Feb 20; 11(4):213-21.
[Curr Biol. 2001]Nat Cell Biol. 2001 Jun; 3(6):596-601.
[Nat Cell Biol. 2001]Science. 2001 Apr 6; 292(5514):107-10.
[Science. 2001]J Biol. 2003; 2(3):20.
[J Biol. 2003]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]J Biol Chem. 1986 Feb 15; 261(5):2189-96.
[J Biol Chem. 1986]Genes Dev. 1997 Nov 15; 11(22):3020-31.
[Genes Dev. 1997]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]Genes Dev. 2005 Oct 15; 19(20):2435-46.
[Genes Dev. 2005]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]Genes Dev. 2005 Oct 15; 19(20):2435-46.
[Genes Dev. 2005]Nature. 1994 Oct 27; 371(6500):762-7.
[Nature. 1994]Nat Cell Biol. 2001 Jun; 3(6):596-601.
[Nat Cell Biol. 2001]Mol Cell Biol. 2003 Dec; 23(24):9117-26.
[Mol Cell Biol. 2003]Genes Dev. 1992 Sep; 6(9):1643-53.
[Genes Dev. 1992]EMBO J. 1999 Nov 1; 18(21):6146-54.
[EMBO J. 1999]Genes Dev. 1999 Dec 15; 13(24):3191-7.
[Genes Dev. 1999]J Biol Chem. 1986 Feb 15; 261(5):2189-96.
[J Biol Chem. 1986]Mol Cell Biol. 2005 Dec; 25(23):10556-65.
[Mol Cell Biol. 2005]Mol Cell Biol. 2005 Dec; 25(23):10556-65.
[Mol Cell Biol. 2005]Biochem Soc Trans. 2005 Dec; 33(Pt 6):1231-41.
[Biochem Soc Trans. 2005]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]Genes Dev. 2005 Oct 15; 19(20):2435-46.
[Genes Dev. 2005]Proc Natl Acad Sci U S A. 1999 Nov 9; 96(23):13118-23.
[Proc Natl Acad Sci U S A. 1999]Genes Dev. 2003 Aug 15; 17(16):2006-20.
[Genes Dev. 2003]J Clin Endocrinol Metab. 1965 Oct; 25(10):1375-84.
[J Clin Endocrinol Metab. 1965]Mol Cell Biol. 1990 Dec; 10(12):6172-80.
[Mol Cell Biol. 1990]Nat Cell Biol. 2001 Jun; 3(6):596-601.
[Nat Cell Biol. 2001]Mol Cell Biol. 2003 Dec; 23(24):9117-26.
[Mol Cell Biol. 2003]DNA Res. 1997 Feb 28; 4(1):61-6.
[DNA Res. 1997]EMBO J. 1999 Nov 1; 18(21):6146-54.
[EMBO J. 1999]Genes Dev. 1999 Dec 15; 13(24):3191-7.
[Genes Dev. 1999]